The Hematopoietic Cell Transplant-Co-Morbidity Index (HCT-CI) Predicts Outcomes After T Cell Depleted (TCD) Allogeneic HCT For AML and MDS

Izaskun Ceberio; Patrick Hilden; Sean M. Devlin; Molly A Malloy; Juliet N Barker; Hugo Castro-Malaspina; Ann A. Jakubowski; Guenther Koehne; Esperanza B Papadopoulos; Doris M Ponce; Craig S. Sauter; Marcel R.M. van den Brink; James W. Young; Richard J. O'Reilly; Sergio Giralt; Jenna D Goldberg; Miguel-Angel Perales

The Hematopoietic Cell Transplant-Co-Morbidity Index (HCT-CI) Predicts Outcomes After T Cell Depleted (TCD) Allogeneic HCT For AML and MDS

Izaskun Ceberio, Patrick Hilden, Sean M. Devlin, Molly A Malloy, Juliet N Barker, Hugo Castro-Malaspina, Ann A. Jakubowski, Guenther Koehne, Esperanza B Papadopoulos, Doris M Ponce, Craig S. Sauter, Marcel R.M. van den Brink, James W. Young, Richard J. O'Reilly, Sergio Giralt, Jenna D Goldberg, Miguel-Angel Perales

Miami Cancer Institute

Research output: Contribution to conference › Presentation

Original language	American English
State	Published - Nov 15 2013
Event	Blood - Duration: Jan 1 2020 → …

Conference

Conference	Blood
Period	1/1/20 → …

Disciplines

Medicine and Health Sciences
Immunology and Infectious Disease

Cite this

Ceberio, I., Hilden, P., Devlin, S. M., Malloy, M. A., Barker, J. N., Castro-Malaspina, H., Jakubowski, A. A., Koehne, G., Papadopoulos, E. B., Ponce, D. M., Sauter, C. S., van den Brink, M. R. M., Young, J. W., O'Reilly, R. J., Giralt, S., Goldberg, J. D., & Perales, M.-A. (2013). The Hematopoietic Cell Transplant-Co-Morbidity Index (HCT-CI) Predicts Outcomes After T Cell Depleted (TCD) Allogeneic HCT For AML and MDS. Blood.

Ceberio, I, Hilden, P, Devlin, SM, Malloy, MA, Barker, JN, Castro-Malaspina, H, Jakubowski, AA, Koehne, G, Papadopoulos, EB, Ponce, DM, Sauter, CS, van den Brink, MRM, Young, JW, O'Reilly, RJ, Giralt, S, Goldberg, JD & Perales, M-A 2013, 'The Hematopoietic Cell Transplant-Co-Morbidity Index (HCT-CI) Predicts Outcomes After T Cell Depleted (TCD) Allogeneic HCT For AML and MDS', Blood, 1/1/20.

@conference{9aec6c7e979e40ebbf8ffc5390ade669,

title = "The Hematopoietic Cell Transplant-Co-Morbidity Index (HCT-CI) Predicts Outcomes After T Cell Depleted (TCD) Allogeneic HCT For AML and MDS",

author = "Izaskun Ceberio and Patrick Hilden and Devlin, {Sean M.} and Malloy, {Molly A} and Barker, {Juliet N} and Hugo Castro-Malaspina and Jakubowski, {Ann A.} and Guenther Koehne and Papadopoulos, {Esperanza B} and Ponce, {Doris M} and Sauter, {Craig S.} and {van den Brink}, {Marcel R.M.} and Young, {James W.} and O'Reilly, {Richard J.} and Sergio Giralt and Goldberg, {Jenna D} and Miguel-Angel Perales",

note = "Introduction Ex vivo TCD Allogeneic-HCT results in long-term relapse-free (RFS) and overall survival (OS) in patients with AML in CR or MDS, with a low incidence of acute and chronic graft-versus-host disease (GVHD). The HCT-CI predicts non-relapse mortality (NRM) and 1-year survival in recipients of conventional grafts.; Blood ; Conference date: 01-01-2020",

year = "2013",

month = nov,

day = "15",

language = "American English",

}

TY - CONF

T1 - The Hematopoietic Cell Transplant-Co-Morbidity Index (HCT-CI) Predicts Outcomes After T Cell Depleted (TCD) Allogeneic HCT For AML and MDS

AU - Ceberio, Izaskun

AU - Hilden, Patrick

AU - Devlin, Sean M.

AU - Malloy, Molly A

AU - Barker, Juliet N

AU - Castro-Malaspina, Hugo

AU - Jakubowski, Ann A.

AU - Koehne, Guenther

AU - Papadopoulos, Esperanza B

AU - Ponce, Doris M

AU - Sauter, Craig S.

AU - van den Brink, Marcel R.M.

AU - Young, James W.

AU - O'Reilly, Richard J.

AU - Giralt, Sergio

AU - Goldberg, Jenna D

AU - Perales, Miguel-Angel

N1 - Introduction Ex vivo TCD Allogeneic-HCT results in long-term relapse-free (RFS) and overall survival (OS) in patients with AML in CR or MDS, with a low incidence of acute and chronic graft-versus-host disease (GVHD). The HCT-CI predicts non-relapse mortality (NRM) and 1-year survival in recipients of conventional grafts.

PY - 2013/11/15

Y1 - 2013/11/15

UR - http://www.bloodjournal.org/content/122/21/2045.abstract?sso-checked=true

M3 - Presentation

T2 - Blood

Y2 - 1 January 2020

ER -

The Hematopoietic Cell Transplant-Co-Morbidity Index (HCT-CI) Predicts Outcomes After T Cell Depleted (TCD) Allogeneic HCT For AML and MDS

Conference

Disciplines

Other files and links

Cite this